SecBot SecBot
Insider Cluster (4 insiders) ·Filed Sep 30, 2026

ANIX

Anixa Biosciences Inc
BULLISH
Impact 5/10
Horizonweeks Processed25d 21h ago
Insider cluster: 4 insiders, $0.2M total
Actionable Insight ▲ Bullish

The cluster is 100% buys with C-suite and board participation, a textbook bullish insider signal. The CEO and President/CFO both bought, which historically carries the strongest predictive power. Monitor for upcoming catalysts (pipeline updates, partnership news, or earnings) that may have motivated this coordinated buying.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+5d
ANIX ▲ +0.68% at T+5d
LONG call ✓ call won +0.68% · α vs SPY -1.23% · entry $2.93 → $2.95
Next anchor: T+20d in 2d
Latest observation: T+17 +5.35% FF3 residual α
Entry anchored
Sep 30, 10:25 AM ET
via 1-min bar
T+1d
-5.46%
call -5.46% · α -5.64%
$2.77
settled 25d ago
T+5d
+0.68%
call +0.68% · α -1.23%
$2.95
settled 19d ago
T+20d
Pending
in 2d
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Four Anixa insiders, including the CEO, President/CFO, and two directors, made open-market purchases totaling $181K over a week. The cluster is 100% buys with C-suite participation, a strong bullish signal per the insider-buying literature, though the total value is modest relative to the company's market cap.

Key Financial Metrics

Direction
buying
Total Value
$181.0K
Insiders
4

Key Facts

  • CEO Amit Kumar bought 7,000 shares at $2.78 ($19K) on 2026-09-24
  • President/COO/CFO Michael Catelani bought 5,500 shares at $2.84 ($16K) on 2026-09-30
  • Director Lewis Titterton bought 49,000 shares at $2.69 ($132K) on 2026-09-23
  • Director Arnold Baskies bought 5,000 shares at $2.76 ($14K) on 2026-09-24
  • Total cluster value: $181K in open-market purchases
  • All four trades are open-market buys (code P) — no 10b5-1 or tax-withholding transactions

Financial Impact

$181K in insider open-market purchases, representing approximately 0.06% of market cap (based on ~$326M market cap at $2.78/share)

insider ownershipmarket signal

Risk Factors

  • Total dollar value ($181K) is modest at ~0.06% of market cap — not a large capital commitment
  • No company news or catalyst was disclosed alongside the purchases
  • Insider buying at a small biotech can reflect personal conviction rather than near-term catalysts

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIX-1790778378373
3 reports for ANIX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ANIX — sortable, filterable
TypeNow
Sep 30, 2026
25d ago
Insider Cluster
BULLISH ★ 5/10
$2.93 $2.95▲ +0.68%▼ −1.23%$2.99 (+2.05%)
Sep 28, 2026
27d ago
Insider Cluster
BULLISH ★ 4/10
$2.79 $2.95▲ +5.73%▲ +4.53%$2.99 (+7.17%)
Jun 17, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.69 $2.74▲ +1.86%▲ +2.90%$2.99 (+11.15%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 1h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026